Filter By Year
Kite Appoints Gallia Levy, MD, PhD, as Global Head of Clinical Development and Laura Alquist as Global Head of Technical Operations
Kite Receives U.S. FDA Regenerative Medicine Advanced Therapy Designation for the Evaluation of Yescarta® (axicabtagene ciloleucel) CAR T-cell Therapy as First-Line Treatment for Patients with High-Risk Large B-Cell Lymphoma